Bitcoin Price Forecast: BTC bulls aim for $13,000 as soon as they break past this level
Fidelity Digital Assets (FDA) released an October 2020 report titled “Bitcoin Investment Thesis.” In the report, the investment firm specified Bitcoin's importance as an uncorrelated alternative investment to offer portfolio optimization benefits.
Fidelity simulated sample portfolios with 60% equities and 40% fixed income instruments. The allocations were diversified with Bitcoin at a rate of 1 to 3%. In each of the scenarios, the portfolio holding higher amounts of BTC performed much better.
Bitcoin Cash Price Analysis: BCH at the tipping point as reversal looms
Bitcoin Cash consistent rally since the beginning of October appears to be reaching its limit. The digital asset continued with the mission of breaking barriers even when Bitcoin, Ethereum and other digital assets stalled. At the moment, bulls are fixated on overcoming the seller congestion at $280. However, a reversal is anticipated in the coming sessions based on various technical indicators.
This week, Grayscale Investment announced a record-breaking quarterly performance with inflows of over $1 billion. The company added that the year-to-date investment into various "products had surpassed $2.4 billion."
EOS Price Analysis: Block.One to launch a suite of services, EOS unaffected
EOS has charted the death cross pattern in its daily chart. The Ethereum killer has faced repeated rejections at the 200-day SMA.
On October 4, EOS bounced up from the $2.48 support line and reached $2.70, where it faced rejection from the 200-day SMA and dipped slightly to $2.60. The 200-day SMA has crossed over the 50-day SMA to chart the death cross pattern, a heavily bearish sign. To add further credence to our bearish outlook, the MACD also shows decreasing bullish momentum.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.